Further evidence of false negative screening for lupus anticoagulants

Thrombosis Research

Volumn 121, Issue 4, 2008, Pages 477-484

  Moore, G W ^a   Henley, A ^a   Greenwood, C K ^a   Rangarajan, S ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Confirmatory tests; False negative screening; Lupus anticoagulant; Mixing studies

Indexed keywords

LUPUS ANTICOAGULANT;

ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FALSE NEGATIVE RESULT; HUMAN; PRIORITY JOURNAL; SCREENING TEST; THROMBOPLASTIN TIME; THROMBOSIS;

FALSE NEGATIVE REACTIONS; HUMANS; LUPUS COAGULATION INHIBITOR; PARTIAL THROMBOPLASTIN TIME; REFERENCE VALUES;

EID: 38649113251     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.05.018     Document Type: Article

References (34)

1. Arnout J. Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants. Thromb Haemost 86 (2001) 83-91
2. Bick R.L. The antiphospholipid thrombosis syndromes: a common multidisciplinary medical problem. Clin Appl Thromb Hemost 3 (1997) 270-283
3. Triplett D.A. New diagnostic strategies for lupus anticoagulants and antiphospholipid antibodies. Haemostasis 24 (1994) 155-164
4. Greaves M., Cohen H., Machin S.J., and Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 109 (2000) 704-715
5. Brandt J.T., Triplett D.A., Alving B., and Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 74 (1995) 1185-1190
6. Triplett D.A. Frequent difficulties encountered in the laboratory diagnosis of antiphospholipid-protein antibodies. Ann Med Interne 147 suppl 1 (1996) 5-9
7. Jennings I., Kitchen S., Woods T.A.L., Preston F.E., and Greaves M. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK national external quality control scheme (NEQAS) for blood coagulation. Thromb Haemost 77 (1997) 934-937
8. Moore G.W., and Savidge G.F. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied. Thromb Res 118 (2006) 523-528
9. Jacobsen E.M., and Wisløff F. False negative screening tests for lupus anticoagulants - an unrecognised problem?. Thromb Res 82 (1996) 445-451
10. Moore G.W., Smith M.P., Patel Y., and Savidge G.F. The Activated Seven Lupus Anticoagulant (ASLA) assay: a new test for lupus anticoagulants (LAs). Evidence that some LAs are detectable only in extrinsic pathway based assays. Blood Coagul Fibrinolysis 13 (2002) 261-269
11. Machin S.J., Giddings J.C., Greaves M., Hutton R.A., Mackie I.J., Malia R.G., et al. Guidelines on testing for the lupus anticoagulant. J Clin Pathol 44 (1991) 885-889
12. Gardiner C., Mackie I.J., Malia R.G., Jones D.W., Winter M., Leeming D., et al. The importance of locally derived reference ranges and standardised calculation of dilute Russell's Viper venom time results in screening for lupus anticoagulant. Br J Haematol 111 (2000) 1230-1235
13. 2-glycoprotein I. Thromb Haemost 81 (1999) 929-934
14. Jennings I., Greaves M., Mackie I.J., Kitchen S., Woods T.A., and Preston F.E. Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br J Haematol 119 (2002) 364-369
15. Forastiero R.R., Cerrato G.S., and Carreras L.O. Evaluation of recently described tests for detection of the lupus anticoagulant. Thromb Haemost 72 (1994) 728-733
16. Haemostasis Committee of the "Sociéte Française De Biologie Clinique". Laboratory heterogeneity of the lupus anticoagulant: a multicentre study using different clotting assays on a panel of 78 samples. Thromb Res 66 (1992) 349-364
17. 2-glycoprotein I. Thromb Haemost 81 (1999) 929-934
18. II phases necessary?. Br J Haematol 86 (1994) 583-589
19. Male C., Lechner K., Speiser W., and Pabinger I. Transient lupus anticoagulants in children: stepwise disappearance of diagnostic features. Thromb Haemost 83 (2000) 174-175
20. Clyne L.P., Yen Y., Kriz N.S., and Breitenstein M.G. The lupus anticoagulant: high incidence of 'negative' mixing studies in a human immunodeficiency virus-positive population. Arch Pathol Lab Med 117 (1993) 595-601
21. Moore G.W., Savidge G.F., and Smith M.P. Improved detection of lupus anticoagulants by the dilute Russell's Viper venom time. Blood Coagul Fibrinolysis 11 (2000) 767-774
22. Jacobsen E.M., Barna-Cler L., Taylor J.M., Triplett D.A., and Wisløff F. The evaluation of clotting times in the laboratory detection of lupus anticoagulants. Thromb Res 104 (2001) 275-282
23. Brancaccio V., Ames P.R., Glynn J., Iannaccone L., and Mackie I.J. A rapid screen for lupus anticoagulant with good discrimination from oral anticoagulants, congenital factor deficiency and heparin, is provided by comparing a sensitive and insensitive APTT reagent. Blood Coagul Fibrinolysis 8 (1997) 155-160
24. Lawrie A.S., Mackie I.J., Purdy G., and Machin S.J. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers. Thromb Haemost 81 (1999) 758-762
25. Cappucci G., Grandone E., Guiliani N., Margaglione M., and Di Minno G. The use of frozen-thawed platelet-derived phospholipids as a confirmatory test for the diagnosis of lupus anticoagulants. Comparison with two commercial confirmatory system tests. Thromb Res 94 (1999) 373-380
26. Dragoni F., Minotti C., Palumbo G., Faillace F., Redi R., Bongarzoni V., et al. As compared to kaolin clotting time, silica clotting time is a specific and sensitive automated method for detecting lupus anticoagulant. Thromb Res 101 (2001) 45-51
27. Rooney A.M., McNally T., Mackie I.J., and Machin S.J. The Taipan snake venom time: a new test for lupus anticoagulant. J Clin Pathol 47 (1994) 497-501
28. Moore G.W., Smith M.P., and Savidge G.F. The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinised patients with lupus anticoagulants. Blood Coagul Fibrinolysis 14 (2003) 307-312
29. Moore G.W., Tugnait S., and Savidge G.F. A new generation dilute Russell's viper venom time assay system for lupus anticoagulants: evaluation of detection utilising frozen regents and controls. Br J Biomed Sci 62 (2005) 127-132
30. Triplett D.A., Barna L.K., and Unger G.A. A hexagonal (II) phase phospholipid neutralisation assay for lupus anticoagulant detection. Thromb Haemost 70 (1993) 787-793
31. Lesperance B., David M., Ruach J., Infante-Rivard C., and Rivard G.E. Relative sensitivity of different tests in the detection of low titre lupus anticoagulants. Thromb Haemost 60 (1988) 217-219
32. Tirado I., Mateo J., Soria J.M., Oliver A., Martinez-Sanchez E., Vallve C., et al. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 93 (2005) 468-474
33. Tripodi A., Chantarangkul V., Martinelli I., Bucciarelli P., and Mannucci P.M. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 104 (2004) 3631-3634
34. Smirnov M.D., Triplett D.T., Comp P.C., Esmon N.L., and Esmon C.T. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest 95 (1995) 309-316